Zusammenfassung
Risikofaktoren sind Merkmale, die mit einem erhöhten Erkrankungsrisiko assoziiert sind. Risikofaktoren haben sowohl in der Primärprävention des ischämischen Schlaganfalls als auch in der klinischen Praxis und der epidemiologischen Forschung eine große Bedeutung. Die zugrunde liegenden Modelle, Methoden und Studiendesigns sind jedoch oft nicht genügend bekannt. Auf der Basis von Interventionsstudien, Kohortenstudien, Fall-Kontroll-Studien und Metaanalysen geben wir in der vorliegenden Arbeit einen aktuellen Überblick über die Primärprävention der wichtigsten etablierten und potenziell beeinflussbaren Risikofaktoren des ischämischen Schlaganfalls. Jeder Risikofaktor wurde nach einem einheitlichen Schema eingeschätzt und systematisch nach Interventionstyp, Evidenzniveau, Risikoreduktion und Prävalenz ausgewertet.
Summary
Risk factors are traits which can increase disease risk. In the case of ischemic stroke, risk factors have important roles in primary prevention, clinical practice, and epidemiological research. However, the underlying models, methods, and suited study design are often unknown. Based on interventions, cohort studies, case control studies, and meta-analyses, we give an up-to-date overall survey of the most important established and modifiable risk factors in the primary prevention of ischemic stroke. Each risk factor was assessed using a uniform pattern and systematically analyzed according to intervention type, evidence level, risk reduction, and prevalence.
Literatur
(1994) Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation. Analysis of pooled data from five randomized controlled trials. Arch Intern Med 154: 1449–1457
(2002) Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet 360: 1903–1913
(2002) Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women’s Health Initiative randomized controlled trial. JAMA 288: 321–333
Abbott RD, Donahue RP, MacMahon SW et al. (1987) Diabetes and the risk of stroke. The Honolulu Heart Program. JAMA 257: 949–952
Benavente O, Moher D, Pham B (1998) Carotid endarterectomy for asymptomatic carotid stenosis: a meta-analysis. BMJ 317: 1477–1480
Blauw GJ, Lagaay AM, Smelt AH et al. (1997) Stroke, statins, and cholesterol. A meta-analysis of randomized, placebo-controlled, double-blind trials with HMG-CoA reductase inhibitors. Stroke 28: 946–950
Boushey CJ, Beresford SA, Omenn GS et al. (1995) A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes. JAMA 274: 1049–1057
Bucher HC, Griffith LE, Guyatt GH (1999) Systematic review on the risk and benefit of different cholesterol-lowering interventions. Arterioscler Thromb Vasc Biol 19: 187–195
Bushnell CD,Goldstein LB (2000) Diagnostic testing for coagulopathies in patients with ischemic stroke. Stroke 31: 3067–3078
Chambers BR, You RX, Donnan GA (2000) Carotid endarterectomy for asymptomatic carotid stenosis. Cochrane Database Syst Rev CD001923
Cina CS, Clase CM, Haynes BR (1999) Refining the indications for carotid endarterectomy in patients with symptomatic carotid stenosis: A systematic review. J Vasc Surg 30: 606–617
Collins R, Peto R, MacMahon S et al. (1990) Blood pressure, stroke, and coronary heart disease. Part 2, Short-term reductions in blood pressure: overview of randomised drug trials in their epidemiological context. Neurol Clin 335: 827–838
Corrao G, Bagnardi V, Zambon A et al. (1999) Exploring the dose-response relationship between alcohol consumption and the risk of several alcohol-related conditions: a meta-analysis. Addiction 94: 1551–1573
Corvol JC, Bouzamondo A, Sirol M et al. (2003) Differential effects of lipid-lowering therapies on stroke prevention: a meta-analysis of randomized trials. Arch Intern Med 163: 669–676
Djousse L, Ellison RC, Beiser A et al. (2002) Alcohol consumption and risk of ischemic stroke: The Framingham Study. Stroke 33: 907–912
Donahue RP, Abbott RD, Reed DM et al. (1986) Alcohol and hemorrhagic stroke. The Honolulu Heart Program. JAMA 255: 2311–2314
Ernst E,Resch KL (1993) Fibrinogen as a cardiovascular risk factor: a meta-analysis and review of the literature. Ann Intern Med 118: 956–963
Gillum LA, Mamidipudi SK, Johnston SC (2000) Ischemic stroke risk with oral contraceptives: A meta-analysis. JAMA 284: 72–78
Hart RG, Benavente O, McBride R et al. (1999) Antithrombotic therapy to prevent stroke in patients with atrial fibrillation: a meta-analysis. Ann Intern Med 131: 492–501
Heinzlef O, Cohen A, Amarenco P (1997) An update on aortic causes of ischemic stroke. Curr Opin Neurol 10: 64–72
Iso H, Jacobs DR Jr, Wentworth D et al. (1989) Serum cholesterol levels and six-year mortality from stroke in 350,977 men screened for the multiple risk factor intervention trial. N Engl J Med 320: 904–910
Kawachi I, Colditz GA, Stampfer MJ et al. (1993) Smoking cessation and decreased risk of stroke in women. JAMA 269: 232–236
Kelly PJ, Rosand J, Kistler JP et al. (2002) Homocysteine, MTHFR 677C-T polymorphism, and risk of ischemic stroke: results of a meta-analysis. Neurology 59: 529–536
Kiely DK, Wolf PA, Cupples LA et al. (1994) Physical activity and stroke risk: the Framingham Study. Am J Epidemiol 140: 608–620
Law MR, Wald NJ, Rudnicka AR (2003) Quantifying effect of statins on low density lipoprotein cholesterol, ischaemic heart disease, and stroke: systematic review and meta-analysis. BMJ 326: 1423
MacMahon S, Peto R, Cutler J et al. (1990) Blood pressure, stroke, and coronary heart disease. Part 1, Prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias. Neurol Clin 335: 765–774
Mulrow CD, Cornell JA, Herrera CR et al. (1994) Hypertension in the elderly. Implications and generalizability of randomized trials. JAMA 272: 1932–1938
Neal B, MacMahon S, Chapman N (2000) Effects of ACE inhibitors, calcium antagonists, and other blood-pressure-lowering drugs: results of prospectively designed overviews of randomised trials. Blood Pressure Lowering Treatment Trialists‘ Collaboration. Neurol Clin 356: 1955–1964
Overell JR, Bone I, Lees KR (2000) Interatrial septal abnormalities and stroke: a meta-analysis of case-control studies. Neurology 55: 1172–1179
Pahor M, Psaty BM, Alderman MH et al. (2000) Health outcomes associated with calcium antagonists compared with other first-line antihypertensive therapies: a meta-analysis of randomised controlled trials. Neurol Clin 356: 1949–1954
Prospective studies collaboration (1995) Cholesterol, diastolic blood pressure, and stroke: 13,000 strokes in 450,000 people in 45 prospective cohorts. Prospective studies collaboration. Neurol Clin 346: 1647–1653
Psaty BM, Lumley T, Furberg CD et al. (2003) Health outcomes associated with various antihypertensive therapies used as first-line agents: a network meta-analysis. JAMA 289: 2534–2544
Psaty BM, Smith NL, Siscovick DS et al. (1997) Health outcomes associated with antihypertensive therapies used as first-line agents. A systematic review and meta-analysis. JAMA 277: 739–745
Reynolds K, Lewis LB, Nolen JD et al. (2003) Alcohol consumption and risk of stroke: a meta-analysis. JAMA 289: 579–588
Ross SD, Allen IE, Connelly JE et al. (1999) Clinical outcomes in statin treatment trials: a meta-analysis. Arch Intern Med 159: 1793–1802
Shinton R,Beevers G (1989) Meta-analysis of relation between cigarette smoking and stroke. BMJ 298: 789–794
Wald DS, Law M, Morris JK (2002) Homocysteine and cardiovascular disease: evidence on causality from a meta-analysis. BMJ 325: 1202
Weih M, Junge-Hulsing J, Mehraein S et al. (2000) Hereditary thrombophilia with ischemic stroke and sinus thrombosis. Diagnosis, therapy and meta-analysis. Nervenarzt 71: 936–945
Whisnant JP (1997) Modeling of risk factors for ischemic stroke; The Willis lecture. Stroke 28: 1839–1843
Wolf PA, D’Agostino RB, Belanger AJ et al. (1991) Probability of stroke: a risk profile from the Framingham Study. Stroke 22: 312–318
Wolf PA, D’Agostino RB, Kannel WB et al. (1988) Cigarette smoking as a risk factor for stroke. The Framingham Study. JAMA 19: 1025–1029
Danksagung
Wir danken Prof. Dr. Wernecke, Institut für medizinische Biometrie der Charité, Prof. Dr. Willich, Institut für Sozialmedizin, Epidemiologie und Gesundheitsökonomie der Charité und Priv.-Doz. Dr. Matthias Endres, Neurologie der Charité für die Unterstützung und kritische Diskussion des Manuskriptes.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Weih, M., Müller-Nordhorn, J., Amberger, N. et al. Risikofaktoren des ischämischen Schlaganfalls. Nervenarzt 75, 324–335 (2004). https://doi.org/10.1007/s00115-003-1639-6
Issue Date:
DOI: https://doi.org/10.1007/s00115-003-1639-6